Topic: Europe
Barriers to entry represent obstacles limiting individuals or entities from entering a particular market. Although barriers to entry allow for only the most qualified and competitive members to thrive, which is a function of capitalism , these roadblocks might also serve as ...
STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale.New European Society of Cardiology guidelines include the medicine, which ...
Question: What is the influence of Western religion on bioethics?. If you think about Western religion, and Western religion is most codified in the Catholic area, the Western religion, Catholics, and other Christians of the same thought, have no problem with biotechnology ...
New report, "Netherlands In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Netherlands In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven ...
Cereplast (NASDAQ:CERP) a leading manufacturer of proprietary bio-based, compostable and sustainable plastics, announced today that it has entered into a multi-million dollar contract with RI.ME. Masterbatch S.r.l., ("RI.ME.") based in Mozzate (CO), Italy, to supply bioplastic resins for use in its masterbatch ...
New report, ""Spain In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Spain In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven ...
New report, "Italy In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Italy In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven ...
Introduction Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the antihormonal therapy cancer brands ...
Misconceptions about the physical and biological world can persist long after the science is settled. The Luddites in the European Parliament are in the same category when it comes to many innovative technologies, even when they represent only evolutionary improvements over existing ...
Teva closes $4.95B deal for German drugmaker Ratiopharm, broadens footprint in EuropeTeva Pharmaceutical has solidified operations further in Europe, announcing Tuesday that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.Teva is the world's largest maker of generic drugs, and said ...